Yvonne Yamanaka is a Principal at venBio Partners with a background in biological engineering and life science company creation. Prior to joining venBio, Yvonne was a member of the venture creation team at Flagship Pioneering. She began her research career leading the development of a novel immunotherapy technology at EMD/Merck Serono. Yvonne received her Ph.D. in Biological Engineering from MIT and her B.S.E. in Biomedical Engineering from Duke University.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies